Follow
Joshua Krieger
Joshua Krieger
Harvard Business School
Verified email at hbs.edu - Homepage
Title
Cited by
Cited by
Year
Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse
A Braun, S Zhang, HE Miettinen, S Ebrahim, TM Holm, E Vasile, MJ Post, ...
Proceedings of the National Academy of Sciences 100 (12), 7283-7288, 2003
1802003
Missing novelty in drug development
J Krieger, D Li, D Papanikolaou
The Review of Financial Studies 35 (2), 636-679, 2022
153*2022
The career effects of scandal: Evidence from scientific retractions
P Azoulay, A Bonatti, JL Krieger
Research Policy 46 (9), 1552-1569, 2017
1322017
Retractions
P Azoulay, JL Furman, JL Krieger, F Murray
Review of Economics and Statistics 97 (5), 1118-1136, 2015
1282015
Trials and terminations: Learning from competitors’ R&D failures
JL Krieger
Management Science 67 (9), 5525-5548, 2021
1012021
Standing on the Shoulders of Science
JL Krieger, M Schnitzer, M Watzinger
Harvard Business School Working Paper 21-128, 2022
49*2022
Find and replace: R&D investment following the erosion of existing products
JL Krieger, X Li, RT Thakor
Management Science 68 (9), 6552-6571, 2022
402022
The impact of personal genomics on risk perceptions and medical decision-making
JL Krieger, F Murray, JS Roberts, RC Green
Nature Biotechnology 34 (9), 912-918, 2016
322016
Private and social returns to R&D: drug development and demographics
E Benmelech, J Eberly, D Papanikolaou, J Krieger
AEA Papers and Proceedings 111, 336-340, 2021
132021
Are Transformational Ideas Harder to Fund? Resource Allocation to R&D Projects at a Global Pharmaceutical Firm
J Krieger, R Nanda
42022
How Important is Editorial Gatekeeping? Evidence from Top Biomedical Journals
JL Krieger, KR Myers, AD Stern
The Review of Economics and Statistics, 1-33, 2023
3*2023
Evaluation and Learning in R&D Investment
AP Frankel, JL Krieger, D Li, D Papanikolaou
National Bureau of Economic Research, 2023
12023
Scoring and Funding Breakthrough Ideas: Evidence from a Global Pharmaceutical Company
J Krieger, R Nanda, I Hunt, A Reynolds, P Tarsa
Harvard Business School Entrepreneurial Management Working Paper, 2023
2023
Dusting Off the Old Ones: Drug Licensing to Startups, Innovation Success and Efficiency
M Hammoudeh, J Krieger, J Xu
SSRN, 2022
2022
Essays on learning and strategy in research and development
JL Krieger
Massachusetts Institute of Technology, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–15